Pharmacoeconomic analysis to determine the relative costeffectiveness of drugs used for primary open angle glaucoma or ocular hypertension

Various treatment options available for glaucoma differ in terms of expense, effectiveness, and side effects. There is a need of designing a cost effective treatment especially for chronic illness requiring life-long medication which can be beneficial for patients, health care providers and the government. All treatment solutions must be prioritized and rationalised in light of the growing disparity between available health resources and therapeutic options. The primary concern of the economic analysis of glaucoma treatment should be on efficiency—that is, the benefits of the treatment relative to the expenses or sacrifices involved in achieving the goals. Clinical effectiveness alone is no longer sufficient. Given the significance of cost-effectiveness, the objective of this research is to assess the daily and annual costs of treating glaucoma with medications that are now available in India, as well as the cost-effectiveness analysis.

 Hypothesis: As varied treatment options of wide cost range for glaucoma treatment are available in Indian market, a more economically sustainable anti-glaucoma medication treatment protocol can be designed by conducting cost-effectiveness analysis of these drugs.

Research question: Given the long-term financial burden of glaucoma therapy, can a more economically viable treatment protocol be designed for glaucoma patients?